Head-to-head · Value Score
bmiMD vs ShedRx
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, ShedRx a 86. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameShedRx
#15 · Grade A- · Great Deal
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 86 — an est. $99/mo first month, with no teaser step-up baked in. ShedRx isn't out of it: Shoppers who want a low tirzepatide price or a lower-cost oral option instead of weekly injections.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | ShedRx |
|---|---|---|
| Value Score | 89 (A) | 86 (A-) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $139/mo | $299/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
ShedRx
One of the better tirzepatide deals, plus a cheaper oral/sublingual route for the needle-averse.
Why it's a deal
- Competitive $299 tirzepatide — cheaper than most flat-fee rivals
- Offers oral/sublingual forms at a lower entry price
- Both molecules available
The fine print
- States-served list not disclosed
- Compounded only — no brand-name access
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.